|
|
|
|
| LEADER |
02741nam a22005055i 4500 |
| 001 |
5276 |
| 003 |
DE-He213 |
| 005 |
20130725191146.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2009 ne | s |||| 0|eng d |
| 020 |
# |
# |
|a 9781402095979
|9 978-1-4020-9597-9
|
| 024 |
7 |
# |
|a 10.1007/978-1-4020-9597-9
|2 doi
|
| 050 |
# |
4 |
|a R-RZ
|
| 072 |
# |
7 |
|a MBGR
|2 bicssc
|
| 072 |
# |
7 |
|a MED000000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 610
|2 23
|
| 100 |
1 |
# |
|a Chen, George G.
|e editor.
|
| 245 |
1 |
0 |
|a Apoptosis in Carcinogenesis and Chemotherapy
|b Apoptosis in Cancer /
|c edited by George G. Chen, Paul B.S. Lai.
|h [electronic resource] :
|
| 264 |
# |
1 |
|a Dordrecht :
|b Springer Netherlands,
|c 2009.
|
| 300 |
# |
# |
|b online resource.
|
| 336 |
# |
# |
|a text
|b txt
|2 rdacontent
|
| 337 |
# |
# |
|a computer
|b c
|2 rdamedia
|
| 338 |
# |
# |
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
# |
# |
|a text file
|b PDF
|2 rda
|
| 520 |
# |
# |
|a The purpose of this book is to provide information on apoptotic processes involved in major neoplastic diseases and their translations into emerging anti-cancer strategies. The book is divided into 15 chapters, each of which will be focused on one particular cancer (breast, bladder, cervical, colorectal, esophageal, gastric, laryngeal, liver, lung, nasopharyngeal, pancreatic, prostate, thyroid, leukaemia and cutaneous malignant melanoma). A number of established leaders in the field have critically summarized the recent discoveries concerning apoptosis in a particular cancer and its potential for anti-cancer treatment. The book describes how the apoptosis plays a role in the specific carcinogen-induced cellular and molecular changes during the development of the cancer, and critically discusses how the emerging anti-cancer strategy can be built by the utilization of the specific carcinogen-related apoptotic pathway. Therefore, this book will be not only for laboratory-based molecular and cell biologists and biochemists in cancer research but also for clinical oncologists and those working in the pharmaceutical and biotechnological industries.
|
| 650 |
# |
0 |
|a Medicine.
|
| 650 |
# |
0 |
|a Oncology.
|
| 650 |
# |
0 |
|a Toxicology.
|
| 650 |
# |
0 |
|a Cancer
|x Surgery.
|
| 650 |
# |
0 |
|a Cytology.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Biomedicine general.
|
| 650 |
2 |
4 |
|a Apoptosis.
|
| 650 |
2 |
4 |
|a Oncology.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Surgical Oncology.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 700 |
1 |
# |
|a Lai, Paul B.S.
|e editor.
|
| 710 |
2 |
# |
|a SpringerLink (Online service)
|
| 773 |
0 |
# |
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9781402095962
|
| 856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-4020-9597-9
|
| 912 |
# |
# |
|a ZDB-2-SBL
|
| 950 |
# |
# |
|a Biomedical and Life Sciences (Springer-11642)
|